ArticlePolymers2026
Design, Experimental Characterization and Finite Element Validation of Melt Electrowritten PCL/Hydrogel Composites for Pelvic Floor Tissue Repair.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Conventional synthetic meshes for pelvic organ prolapse (POP) frequently cause severe complications, such as tissue erosion, due to a profound mechanical mismatch with native tissue. This study proposes a novel biphasic composite scaffold combining a load-bearing melt electrowritten (MEW) polycaprolactone (PCL) framework with a compliant alginate-gelatin (Alg-Gel) hydrogel matrix. PCL meshes (1.5 and 2.0 mm pores) were infiltrated with varying Alg-Gel ratios (4:3 and 5:2) and structurally evaluated through mechanical testing, swelling/degradation assays in a simulated acidic vaginal environment (pH 4.3), and finite element analysis (FEA). Results demonstrated that the 1.5 mm PCL architecture provides a robust baseline to withstand physiological loads. Notably, the hydrogel matrix provides a viscoelastic damping effect that synergistically improves the overall mechanical stability of the composite. Furthermore, FEA accurately predicted the non-linear macroscopic response of the composite constructs. Modulating the Alg-Gel ratio also enabled precise tuning of swelling capacity (up to 1400%) and degradation kinetics. Ultimately, this biomimetic system offers a highly adaptable, tissue-like protective cushion with enhanced dynamic stability, presenting a versatile platform for future in vivovalidation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.